OraSure Technologies, Inc.

NASDAQ:OSUR

Medical - Instruments & Supplies

Healthcare
$3.59 -3.47%

-$0.16 today

Market cap
$247.88M
Beta
1.01
P/E (TTM)
-4.0
EPS (TTM)
-$1.08
52W Low $2.08High $4.58

Volume 0.49M

Average 0.61M

OSUR Change in Working Capital

Cash absorbed or released by changes in receivables, inventory, payables, and other operating balances.

OraSure Technologies, Inc.NASDAQ: OSUR

Change in Working Capital · Q1 FY2026 · quarter ended Mar 2026

Change in working capital turns positive

Q1 FY2026 change in working capital was $2.71M, compared with -$8.94M a year earlier. Trailing-twelve-month change in working capital was $4.85M. Over 3 fiscal years it compounded at -54.1% a year.

Context

  • Change in working capital amounted to 5.9% of revenue in FY2025, down 4.2 pp from a year earlier.
  • Change in working capital increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly change in working capital holds near $2.71M or moves back toward the trailing-twelve-month quarterly average of $1.21M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$2.71M+14.6% QoQ
Last fiscal yearDec 2025
-$6.8M-136.2% YoY
LTMMar 2026
$4.85M-42.7% YoY
Change in Working Capital past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+130.3%——
1 year-136.2%——
3-year CAGR-54.1%——
5-year CAGR——
10-year CAGR——

Change in Working Capital history

USD · from the cash flow

Latest · FY2025
(6.8M) USD
Year-over-year change
-136.2%

Change in Working Capital vs competitors

How OSUR compares with its peers on the latest reported figures

  • Peers report in different currencies, so change in working capital is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -42.7% is the 3rd highest of 8, against a peer median of -127.9%.
  • Change in working capital amounts to 4.3% of revenue for OSUR, versus a peer median of 8.6%.
OSUR Competitors
Change in Working Capital for OSUR and competitors
Company Period LTM YoY 3-year CAGR% of revenue
STIMNeuronetics, Inc.LTM Mar 2026$11.6M USD+270.0%—7.6%
NTHINeonc Technologies Holdings, Inc.LTM Mar 2026$8.1M USD———
PROFProfound Medical Corp.LTM Mar 2026$5.73M USD-418.7%-32.3%30.4%
OSUROraSure Technologies, Inc.LTM Mar 2026$4.85M USD-42.7%-54.1%4.3%
TARAProtara Therapeutics, Inc.LTM Mar 2026$4.24M USD-538.4%——
NAUTNautilus Biotechnology, Inc.LTM Mar 2026$4.18M USD-8.0%+65.7%—
PREPrenetics Global LimitedLTM Mar 2026$2.39M USD——2.1%
NYXHNyxoah S.A.LTM Mar 2026€1.55M EUR-127.9%+296.7%9.5%
CATXPerspective Therapeutics, Inc.LTM Mar 2026$1.48M USD-243.2%+70.7%239.8%
UTMDUtah Medical Products, Inc.LTM Mar 2026$662K USD-61.4%—1.8%
Peer median (excluding OSUR) —-127.9%+68.2%8.6%

Competitors are the stored peer set for OSUR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(23M)(17.93M)53.66M(19.5M)(68.73K)
Depreciation & Amortization12.5M15.54M20.94M10.87M10.19K
Deferred Income Tax1.03M(1.65M)102K(657K)(103)
Stock-Based Compensation7.81M11.62M10.73M11.92M10.15K
Change in Working Capital(38.44M)(70.56M)45.76M18.82M(6.8M)
Accounts Receivables(6.45M)(25.16M)31.12M15.87M1.95M
Inventory(27.94M)(43.05M)48.23M13.1M3.56M
Accounts Payables3.23M3.96M(26.98M)(7.58M)(1.72M)
Other Working Capital(7.28M)(6.32M)(6.61M)(2.57M)(10.59M)
Other Non-Cash Items4.72M15.79M10.4M5.92M6.8M
Operating Cash Flow(35.38M)(47.2M)141.58M27.37M(49.02K)
Capital Expenditures(48.12M)(63.91M)(10.3M)(3.8M)(4.2K)
Acquisitions (Net)0121K0(5.04M)(3.61K)
Purchases of Investments(25.82M)(22.87M)(74.65M)(53.24M)0
Sales of Investments67.93M47.42M102.44M53.05M0
Other Investing Activities513K60.33M48.67M(30M)1K
Investing Cash Flow(5.5M)21.09M66.15M(39.03M)(6.81K)
Debt Repayment(686K)(1.38M)(1.35M)(842K)(61K)
Common Stock Issued00000
Common Stock Repurchased(2.11M)(2.25M)(1.9M)(3.55M)(15.04M)
Dividends Paid00000
Other Financing Activities(18K)(193K)223K214K15.08M
Financing Cash Flow(2.82M)(3.83M)(3.02M)(4.18M)(16.94K)
Effect of Forex Changes(340K)(2.84M)1.71M(6.82M)4.29K
Net Change in Cash(44.04M)(32.78M)206.43M(22.64M)(68.49K)
Free Cash Flow(83.5M)(111.11M)131.28M23.58M(53.22K)

OraSure Technologies, Inc.

NASDAQ:OSUR

Intrinsic Alpha fair value

Locked

Current Price

$3.59

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.